Patients with DVT did not have significantly different antithrombin III levels on admission but showed a precipitous decrease in antithrombin III levels at 8 hours that remained significantly lower at 16, 24, 48, 72, and 96 hours after admission (Figure 3B). The gene discussed is SERPINC1; the disease is deep vein thrombosis.